Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
about
Pharmacology and physiology of gastrointestinal enteroendocrine cellsNovel Zn2+ Modulated GPR39 Receptor Agonists Do Not Drive Acute Insulin Secretion in Rodents.Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.Fatty acid and mineral receptors as drug targets for gastrointestinal disorders.
P2860
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
@en
type
label
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
@en
prefLabel
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
@en
P2093
P2860
P356
P1476
Discovery of 2-Pyridylpyrimidines as the First Orally Bioavailable GPR39 Agonists.
@en
P2093
Adam Carlson
Anja Castellana
Avirup Bose
Guiqing Liang
Jeffrey Shapiro
Jill Nunez
Luis Llamas
Mike Pietropaolo
Richard Hughes
P2860
P304
P356
10.1021/ML500240D
P577
2014-08-04T00:00:00Z